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The treated end stage renal disease in Catalonia. lsl statistical annual
report of the Catalanish Registry of Renal Patients (RMRC), 1984.
ANDRES E, AUBtA J, LOPEZ J, MORLANS M, OLIVER A, PASCUAL R,
RODA M, SALAMERO P, TEIxIDO J, VILA A, JANE E, VIDAL C,
Nephrology Services and Renal Assistance Program, Health Depart-
ment of Catalonia, Spain. This first statistical report shows the results
of the year ending December 31, 1984, that is, the first since the registry
started to function. Demographic, socioeconomic, other epidemiologi-
cal and clinical data are analized among the patients entering renal
replacement therapy for the first time. A census of the rest of the
patients treated (and not yet introduced to the registry) completes the
report, showing the prevalence (at December 31, 1984) distribution by
age, sex, places of birth and of residence, and treatment modality.
Other variables studied among the patients in the registry are: educa-
tional level, socioeconomic condition, primary renal disease, concom-
itant diseases, degree of uremia severity, socio-laboral rehabilitation
and situation with respect to the transplantation waiting list. In
Catalonia, 2491 patients (415 pmp) were receiving renal replacement
treatment at December31, 1984, 22.3% of them with a functioning graft.
During 1984, 469 new patients were reported, 435 of them living in
Catalonia (incidence of 72.5 pmp) and the rest from adjacent spanish
regions. The number of transplantations performed was of 261 (43
pmp), 216 of them from a cadaver donor. The overall annual lethality
was of 6.5% (mortality of 26.3 pmp).
Functional identity between renal and pulmonary Goodpasture's anti-
gen. MtP.APEIx E, REVERT L, Nephrology Service, Hospital Clinic,
Barcelona, Spain. Pulmonary bleeding in Uoodpasture's syndrome has
been attributed to cross reactivity of the anti-UBM antibody with the
lung basement membrane. In order to find differences between pulmo-
nary and renal antigens that could explain why patients with anti-GBM
disease do not have pulmonary symptoms, we have partially purified,
from normal lung and normal kidneys, the pulmonary and renal
non-collagenous antigens to develop a solid phase radioimmunoassay
for measuring quantitatively, antibodies against GBM and lung base-
ment membrane (LBM). The results obtained with the sera of IS
patients with anti-GBM antibodies show that the values obtained with
the RIA for the GBM highly correlate with that obtained with the RIA
for the LBM (r 0.87, P < 0.001). Absorption experiments of the
antibody activity with pulmonary and renal antigen show that the
anti-GBM activity of the serum of a patient with Goodpasture's
syndrome can be abolished by preabsorbing with pulmonary antigen,
and in the same way, the anti-LBM activity of the same serum can be
abolished preabsorbing with kidney antigen. The excellent correlation
between the RIA for UBM and LBM and the absorption experiments,
suggest that the renal and pulmonary Goodpasture's antigen are func-
tionally identical.
DIstribution of DR antigens in the glomerular disease. ARRIZABALAGA
1', MIRAPEIX E, DARNELL A, VILELLA R, TORRAS A, REVERT L, S.
NefrologIo, L. inmunologia, Hospital Clinic, Barcelona, Spain. In
humans, DR antigens are expressed on endothelium of the normal renal
microvasculature. We studied the DR expression in 48 renal biopsies
from patients with glomerular disease. A monoclonal antibody to
monomorphic determinant of HLA-DR (EDU-1) with indirect im-
munofluorescence (IF) and stain for nonspecific esterase (NSE) were
used. In minimal change disease, membranous glomerulonephritis
(GN), IgA nephropathy and membranoproliferative GN, the pattern of
intraglomerular IF (DR antigens) was similar than the normal kidney. In
acute UN and focal glomeruloesclerosis, a stronger and more extensive
IF in glomerular capillaries was observed. Areas of sclerosis or necrosis
present in necrotizing UN and severe lupus UN, did not show DR
antigens. In rapidly progressive GN, the IF was detected in the
glomerular tufts, whereas it was not in crescents. Regardless of the type
of UN, DR antigens were found in peritubular capillaries, microvessels
and cells infiltrating the interstitium. NSE (monocytes—macrophages)
was identified in interstitial cell infiltrates and within glomerular tuft in
some cases of acute GN, lupus UN, and necrotizing UN. No NSE was
detected in glomerular crescents. Conclusions: 1) No loss of DR
antigens on glomerular and peritubular capillaries or microvessels
occurs in the glomerular disease. 2) The increased DR expression on
intraglomerular capillaries in some UN without endocapillar prolifera-
tion suggest a role for the endothelial cell in local immune reactions. 3)
Monocyte—macrophages are present in the interstitial infiltrates of cells
expressing DR antigens.
Mechanism of the decrease in serum potassium by salbutamol in
chronic renal failure. MONTOLIu J, LENS XM, ANDREU L, Fia VEROLA
D, CASAMITJANA R, LOaz PEDRET J, REVERT L, Nephrology Service,
Diabetes Section and Hormonal Laboratory. Hospital Clinic.
Barcelona, Spain. To study the effect of specific beta-2-adrenergic
stimulation on the transcellular distribution of potassium (K) in chronic
renal failure (CRF), we administered salbutamol (S), 0.5 mg iv. in 15
mm to 20 patients with terminal CRF (glomerular filtration rate less than
5 mI/mm). They were non-diabetic and essentially anuric, and had been
on hemodialysis between six and 132 months (mean 64.4 months). The
test was performed 72 hr after the last hemodialysis. Thirty mm after
termination of the S infusion, serum K dropped from a pretreatment
level of 5.6 0.2 mmole/liter to a final value of 4.5 0.2 mmole/liter
(P < 0.001). There were no significant changes in plasma aldosterone or
arterial pH, but blood glucose and serum insulin levels increased from
90.1 2.4to 128.1 5.7 mg/tOO ml andfrom 23.1 2.1 to 67.7 9.4
jzU/ml respectively (P < 0.001 for both). However, S induced similar
decrements in serum K (— 1.1 to — 1.6 mmole/liter) in three
insulin—dependent diabetic patients in whom free C peptide levels
remained undetectable or subnormal (< 0.53 ng/mt), indicaling serious
impairment of endogenous insulin secretion. The S injection was well
tolerated by the patients and no serious side effects were observed. The
results demonstrate that specific bcta-2-stimulation with salbutamol
facilitates intracellular K uptake in patients with CRF on maintenance
hemodialysis by a direct mechanism independent of pH, aldosterone or
insulin changes. This property might he therapeutically useful in cases
of hyperkalemia.
Pressor action of vasopressin in essential hypertension. LENS XM,
BOTEYA, MARTINEZ—VEA A, GAYA J, REVERTL, Nephrology Service,
Hospital ClInico, Barcelona, Spain. To study if the pressor effect of
vasopressin. (AVP), one of the most potent vasoconstrictor agents in
vitro, plays any role in the pathophysiology of mild or moderate
essential hypertension (F.HT), we determined basal plasma levels in
nine hypertensive patients and in six healthy controls of the same age
and sex, obtaining similar values (3.6 3 vs. 3.8 1.6 pg/mI) ( su).
Orthostatism did not alter significantly these values in any group.
Infusion of progressively increasing doses of AVP (0.25, 0.5, 1 and 2
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ng/kg/min), in spite of reaching similarly stepped plasma levels, caused
a significant change in blood pressure in hypertensive patients (P =
0.017). The decrease in heart rate was identical in both groups. The
effects of the infusion on catecholamines and renin system showed only
a significant decrease in renin activity (P = 0.011) that was correlated
in normal controls with the increments in AVP (P < 0.01). Although in
EHT plasma levels of AVP are normal at rest and in orthostatism, there
is a greater pressor sensitivity with the same heart rate response to the
infusion of exogenous AVP. The inhibition of the renin system, similar
in both groups, is correlated with the increment in AVP only in normal
individuals.
Initial renal failure in multiple myeloma: Characteristics and evolutive
pattern. LENS XM, BLADE J, M0NT0LIu J, REVERT L, ROZMAN C,
Nephrology and Hematology Services, Department of Medicine, Hos-
pital Clinic, Barcelona, Spain. Of a total 206 patients diagnosed of
multiple myeloma in a single center from 1969 until 1985, 22.3% (46
patients, 22 males, mean age 63 9.9 years) had renal failure (serum
creatinine > 2 mg/dl) when diagnosed. The type of multiple myeloma
was: IgG (16), IgA (12), JgD (2), Bence Jones (II) and unknown (5).
Light chains were lambda in 19 patients and kappa in 13. According to
the classification of Dune and Salmon, distribution of patients by stage
was as follows: 1(1), Il(S), III (39) and unknown (1). In 46% of cases,
there was no precipitating factor, and in the remaining, hypercalcemia
was the most frequent associated abnormality. Most patients were
treated continuously or intermittently with alkylating agents. Depend-
ing on the degree of renal failure, three groups emerged: A) serum
creatinine between 2 and 4 mg/dl (N = 22, 10 with hypercalcemia); B)
serum creatinine between 4 and 8 mg/dl (N — 11, 7 with
hypercalcemia); and C) serum creatinine > 8 mg/dl (N = 13, 2 with
hypercalcemia). In 43% of patients from group A, renal failure was
reversible independent of the presence or absence of hypercalcemia. In
70% of patients from group B, renal failure remained stable and only
one received dialysis treatment. Renal failure was irreversible in all
patients from group C, and dialysis was performed in 7 patients, 3 of
whom stay alive at 5, 15 and 20 months, respectively, from the start of
hemodialysis. Mean survival of multiple myeloma with renal failure was
five months. Mean survival of patients with reversible renal failure was
22.5 months, and that of the patients with irreversible renal failure was
only 3.7 months (P < 0.005). Causes of death were: progression of
multiple myeloma 33%, proven infection 30%, hemorrhage 20%,
amyloid cardiomyopathy 5%, renal failure 5% and respiratory failure
(2.5%). Thus: I) almost a fourth of patients with multiple myeloma had
renal failure when diagnosed; 2)86% of these patients were in stage III;
3) minor degrees of renal failure were frequently associated with
hypercalcemia; and 4) severe renal failure was irreversible and carried
a fatal short—term prognosis, although prolonged survival was possible
in some patients with the use of dialysis and chemotherapy.
Prognostic patterns in acute renal failure (ARF). Analysis of 1,000
episodes. CASTELAO AM, GIL-VERNET S. TORRAS J, ANDRES E, GROSTO
JM, ALSINA J, Nephrology Depart,nent, Hospital de Bellvitge
PrIncipes de E,vpaña", Barcelona, Spain. One thousand patients who
developed ARF (plasma urea  16.5 mmole/liter, plasma creatinine 
178 mole/liter were studied in our Hospital between January 1980 and
August 1985. Established ARF (EARF) was diagnosed in 762 cases and
pre-renal failure (PRF) in 238. In each group, we analyzed age (EARF
59.7 20.2, PRF 59.4 18.4), sex (EARF 528 males, 234 females;
PRF 142 males, 96 females) ethiology (dehydration 21.7%,
nephrotoxicity 15.7%, arterial hypotension—low cardiac output 12.6%,
sepsis 12.1%, being multifactorial in many cases), associated illnesses
(arterial hypertension 19%, diabetes mellitus 6.5%, previous nephrop-
athy 6%) and diuresis (oliguric EARF 62.7%, oliguric PRF 31%). Two
hundred and sixty six patients (26.6%) needed dialysis, being more
frequent in oliguric patients (48.5%) than in monoliguric (17.1%), P <
0.01. Two hundred and eighty three patients died (28.3%), 29% in
SARF, 25.6% in PRF. Mortality rate was 34.5% among oliguric patients
and 20.7% among nonoliguric ones. The most frequent causes of
mortality were sepsis (25%), cardiac arrest or arrhitmia (11.3%),
hemorragia (11.5%) and cardio-respiratory complications (10.7%). The
factors, including a bad prognosis, were sex and age (males over 60
years), associated hepatic or hemathological disorders, plurivisceral
disease, as well as the presence of oliguria.
Detection of infected arterio-venous fistulas (AVF) by means of indium-
lil-oxine labelled leukocytes (In-l 11). TORRAS J, MARTIN COMIN J,
ANDRES E, GIL VERNET S, SERON D, ALSINA J, Hospital de Bellvitge,
Barcelona, Spain. Infection of AVF means, in a large number of cases,
the definitive lost of the access and/or the possibility of thromboembol-
ism or sepsis. Its diagnosis in the absence of local signs of infiamation
or supuration can be difficult to establish. The locating of septic focus
has recently been carried out by means of gammagraphic detection of
accumulations of radiolaheled leukocytes. Therefore, the value of this
technique in patients on hemodialysis (HD) with a suspected infection
in the access is considered. We performed eleven studies in ten patients
on an HD program with prolonged high temperatures and without any
apparent focal point. The patients own leukocytes were separated and
labelled with In-ill and reinjected; scyntigraphic images of the ac-
cesses were obtained four and twenty—four hours subsequently. In four
patients, positive scyntigrams were obtained on their AVF in five
studies. During the studies all the hemocultures were positive. In one of
these patients, the scan became negative when hemoculture became
negative. in other patient, because of septic thromboembolism, binding
and resection of AVF was required. In a third patient, his AVF broke
because of mycotic aneurism. Hemocultures from the remaining six
patients were negative. None of them showed a positive study and fever
extinguished by itself. Although the casuistry is reduced, we believe
that this technique can be of great interest in the detection of infected
AVF in HD patients.
Indium-"-oxine autologous labelled platelets in the diagnosis of kidney
allograft rejection under cyclosporine therapy. GairO JM, TORRAS J,
MARTIN—COMIN J, MoRA J, SAnATF I, CASTELAO AM, ROCA M,
ALStNA J, Hospital de Bellvitge, Barcelona, Spain. In °-oxine autol-
ogous labelled platelets has been useful in the diagnosis of renal
allograft rejection (R) under conventional immunosupression. Treat-
ment with cyclosporine (Cy) raises the question of differentiation
between R and Cy nephrotocitity, particularly so in the post-operative
acute tubular necrosis (ATN). We have studied the usefulness of this
method in the diagnosis of R based on the image of the graft area
secondary to the trapping of autologous In°' labelled platelets. The
trapping index (TI) was calculated according to the graft activity vs.
contralateral fossa iliaca ratio. Twenty—seven patients treated with Cy
were studied. In 12 patients with acute R, mean TI was 2.0 0.4 vs. 1.1
0.2 in 15 patients without R (P < 0.001). Mean Cy trough whole
blood levels (RIA) was 381 286 ng/ml in the patients with R vs. 628
286 ng/ml in the patients without R (P < 0.01). Among 18 patients
with post-operative ATN, eight suffered from R, and all 18 but one
(arterial thrombosis) recovered renal function. In the last follow—up, 25
grafts are functioning. One graft failed due to acute vascular rejection
on diuretic phase. These results suggest that this method may be useful
in the management of renal allograft recipients treated with Cy.
Assessment of tolerance in renal transplant recipients on cyclosporine.
ALSINA J, ESPANOL T, GARCIA—SANZ f—A, GRIIc'O J—M, C'ASTELAO
AM, TORRAS J, Hospital Beilvilge, L. Inmunologia, Hospital Vail d
Hehrd, Barcelona, Spain. We assessed the correlation between tol-
erance", clinically defined as stable renal function without rejection,
and mixed lymphocite culture response (MLC) in 18 transplant recipi-
ents (four living donors and 14 cadaver kidneys). Receptor lymphocites
(A) were cultured with donor (B) and control (C) lymphocites, in one
and two—way MLC. The stimulation indexes (S1) were calculated with
FCS (1/10) or recipient sera diluted at 1/10. 1/20, 1/40 and 1/80. With
time SI decreased, although a normal response was maintained. Sera
from "tolerant" patients at 1/10 exerted a blocking effect on one—way
MLC (A-RI; A-Cl) (111 is irradiated donor lymphocites). This effect is
partially allospecific: the same effect ocurred with controls. Recipient
serum diluted at 1/20, 1/40, 1/80 had a stimulating effect on recipient
lymphocites. There is a good correlation between clinical tolerance and
decreased one—way MLC (A-BI; A-Cl) with recipient serum diluted at
1/10, related with basal values (FCS 1/10), or higher dilutions (1/20,
1/40, 1/80). This could allow cyclosporine to be adjusted to the true
requirements.
Plasma levels of granulocyte elastase: its role on the assessment of
hemodialysis membrane biocompatibility. BONAL J, PASTOR C, TEIXID0
f, BONF.T J, SERRA A, LAUZURICA R, ROMERO R, cARALPS A,
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COROMINAS A, Servicio de Nefrologla y Análisis ClInicos, Hospital
Germans Trias y Pujol, Badalona, Spain. Elastase is a proteolytic
enzyme contained in the granulocytes, and its release is triggered by
several stimulus: immune complexes, complement, phagocytosis, etc.
Plasmatic elastase release has been observed during conventional
hemodialysis. In order to assess the potential role of elastase levels in
the evaluation of membrane biocompatibility, a prospective study was
undertaken in six patients who were sequentially treated with mem-
branes made of cuprophan (CU), ethylenvinylalcohol (EVAL),
polymethylmetacrylate (PMM) and polyacrylonitrile (PAN). Total
leukocyte count, plasma hemoglobin and elastase activity—as mea-
sured by an enzyme—linked immunoassay—were performed before and
15 mm and 180 mm during hemodialysis. Results showed that total
leukocyte count decreased at 15 mm: —64% (CU), —54% (EVAL),
— 11% (PMM) and — 2% (PAN). Serum elastase increased significantly
in all types of membranes: at 180 mm elastase levels were 345% (CU),
197% (EVAL), 265% (PMM) and 168% (PAN). Use of PAN and EVAL
membranes was associated with a significant lesser release of elastase
than CU membrane (Wilcoxon's rank test). No correlation was found
between increased elastase levels and decrease of total leukocyte
count. We conclude that serum elastase can be helpful in the evaluation
of hemodialysis membrane biocompatibility. In the present study, PAN
membrane was associated with lesser leukocyte decrease and elastase
release. Further studies are needed to investigate the mechanism of
elastase release during hemodialysis, which appears to be independent
from the decrease of total leukocyte count.
Furosemide i.v. administration test to check distal acidification normal
values in adults. SARACHO R, VALLO A, BIDEA J, MoRAN J,
ARANZABAL J, GAINZA J, LAMPREABE I, Pediatrics and Nefrology
Units, Ciudad S. Cruces, Bilbao, Spain. Twenty—two adults (average
age 30 years, SD 10) whose ratio F/M was = 1.00, were studied. At first,
basal urine and blood samples were taken. After that, an i.v. bolus of F
(1 mg/kg of wt) was injected. Then, four urine samples were collected at
30, 60, 120 and 180 mm. A second blood sample was taken at 180 mm.
There was an increase in the following parameters (P < 0.001 using
t-paired test): A) plasma renin activity (PRA) average increment = 3.1
ng/ml/hr (4.2-fold of basal level, rank = 1.7—9-fold) B) plasma aldos-
terone(PA) ii = 132 pg/ml (2.4-fold of basal level rank = 1.5—5-fold) C)
net acid excretion (NAB) basal ,t = 39 vs. 69 mcrEq/min, mediated by
ammonium excretion (AE), basal = 24 vs. 42 mcrEq/min in 60% and
by titratable acid (AT) in 40%, the rank of maximum AE rate was 14 to
65 mcrEq/min. D) fractional potassium excretion (FKE), basal x = 9%
vs. 40%, rank of maximum FKE = 20%-77%. D) Urine acidity
determined by pHurine. The lowest pHu was = 4.5 (rank = 4.2—5.1).
This was seen at 120 mm in 64% of cases. In this paper we report the
ability of F to stimulate PRA and FA secretion, potassium and
ammoniurn excretion, and lowering urine pH. This may be useful for
ATR and renal hyperkalemia diagnosis.
Uremic osteomalacia (OM) not induced by aluminum (AL):
Histomorphometrics and biochemical features. LORENZO V, TORRES A,
GLEZ POSADA J, MENDEZ M, LOPEZ A, DIAz L, Hospital "Virgen de
Candelaria", Hospital Gral. YClInico. Tenerife, Canary Island, Spain.
Forty patients with terminal uremia were separated into four groups (17
predialysis and 23 on hemodialysis) on the basis of bone histology: 1)
mild: 8 (20%); 2) osteitis fibrosa (OF): 15 (37.5%); 3) OM:9 (22.5%); 4):
mixed (OM + OF): 5 (12.5%) and 3 (7.5%) were normals. No histolog-
ical AL deposits were present in all except 1 OM patient. The
histomorphometric and biochemical data are shown in the Table:
TBV M OV F PTH-C AP
Mild 21,44 93,40 7,08 0,29 3,65 174,43
OF 23,95 88,04 11,19 6,41 7,26 606,69
OM 32,52 77,67 22,2 0,25 5,12 377,43
Mixed 34,00 72,12 27,84 4,58 8,00 1048,2
Controls 16—30 >95 <5 0 0,3—1,2 270
TBV: % trabecular bone volume. M: % mineralized bone. OV: %
osteoid volume. F: % fibrosis. PTH-C:ng/ml. AP: pJml. In contrast to
what occurs in AL-related OM, these OM patients have a trend toward
higher TBV. In addition patients with pure OM (as compared with OF)
have relatively lower PTH and AP levels, while higher values are more
frequently encountered in mixed disease. In summary, the presentation
form of uremic OM is heterogeneus (pure or with OF), and other
pathogenetics factors different from AL are implicated and need to be
explored further.
Treatment with cyclosporine (Cs) in renal transplantation (RT) and
change to azathioprine (Az) after three months. VALERA A,
GLEZ—MOLINA M, FRUTOS MA, RAMOS B, LOPEZ DE NO VALES E,
Hospital R, Carlos Haya, Malaga, Spain. Between May 1984 and May
1985, we treated 23 RT patients (I from LRD) with Cs and low doses of
steroid. The patients received Cs 15 mg/kg/day by mouth or 1/3 of this
dose IV on days 1—3, adjusting as necessary for having total blood levels
of 250 to 800 ng/ml. Three months after RT, Az was changed for Cs in
a stepwise fashion during 21 days. We compare these results with those
of 15 patients transplanted during the months just before May 1984, in
whom Az was used with low doses of steroid. The number of patients
with postoperative acute tubular necrosis was similar in both groups (P
= NS), the episodes of acute rejection was lower (P < 0.05) in the
group of patients treated with Cs, as was the incidence of infections (P
< 0.05). The plasma creatinine levels at three months was similar in
both groups, and plasma K levels were higher in the Cs group. After the
change to Az, 20% of the patients developed an episode of acute
rejection, all of whom responded to steroids bolus or to the reinstitution
of Cs. In conclusion, we think that if the change is to be made, it should
be under close control of the patient.
Effects on blood pressure and hemodynamics of calcium channel
blockers in aged rats. MAClAS J, VILLAMEDIANA L, CARAMELO C,
BLANCHARTY A, R-PUYOL D, LOPEZ—NO VOA JM, Hospital
Universitario (Salamanca) and Fundacion Jimenez Diaz, Madrid,
Spain. Calcium channel blockers (C.B.), reduce blood pressure (B.P.)
among hypertensives. It is believed that C.B. exhibits regional vasodi-
lator properties. We studied the influence of Nifedipine (NO on blood
pressure and blood flow distribution (B.F.D.) in three groups of
normotensive and spontaneously hypertensive old (18 months)
Sprague—Dawley rats (N = 17) and the effect of the solvent used to
administer Nf (N = 6). BP, cardiac output (CO.), total periferal
resistences (P.R.) and blood flow to brain (C.F.), kidney (K.F.), liver
(L.F.), stomach (S.F.), small and large bowel, spleen, red muscle and
skin were measured with two species of 15 zm microspheres in basal
condition and following 1, 3 and 5 mg/kgbw of oral Nf or solvent.
Results show that Nf diminished BP in similar range in normotensive
and spontaneously hypertensive old rats. Nf reduced P.R. without
alterate C.O. C.F. was significantly reduced in hypertensive rats. Nf
highly increased C.F. in hypertensive rats and to a lesser extent in
normotensive animals. The more effective dose to increase C.F. was
that of 1 mg/kg body wt Nf augment L.F. and S.F. Nf does not influence
blood flow to the rest of the explored organs. The solvent have no
influence on B.F.D. and BP. The dose of 5mg was lethal in the majority
of the rats.
Effect of uremia on Na ,K cotransport system in erythrocytes (E)
from hemodialysis patients. VIRTO R, DIAz J, DIEZ—TEJEIRO R, YAP L,
ERRASTI P. PURROY A, Division of Nephrology, University Clinic,
Pamplona, Spain. We examined in fresh E by established flux assays
the Na,K cotransport (COT) activity in 14 hemodialysis patients
(HD), 8 renal transplant recipients with normal renal function (TR) and
27 controls (C). Mean outward NA COT flux was lower (P < 0.005) in
HD compared to C (47 10 vs. 160 13 tM/liter cells/h). Mean
outward Na COT flux was low in TR (117 35 LM/hter cells/hr) but
was not significantly different from C. Intracellular Na content was
lower (P < 0.01) in HD compared to C (5.8 0.3 vs. 7.0 0.1 mM/liter
cells). The rate constant for outward Na COT flux was lower (P <
0.005) in HD compared to C (0.007 0.002 vs. 0.022 0.002 hr).
There was no difference in mean COT values pre- and post-
hemodialysis. There was no difference in mean COT values of E from
C after incubation for two hr at 37°C in plasma from HD. We have
studied the stimulation of outward Na COT flux by intracellular Na
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in E from HD. The maximal rate of outward Na COT was lower (P <
0.001) in I-ID compared to C (364 40 vs. 900 60 .rM/liter cells/hr).
Half—maximal COT stimulation by intracellular Na was not different
in HD and C (9.86 1.80 vs. 8.50 1.50 mM/liter cells/br). Our results
suggest that COT is suppressed in E from uremic patients. An intrinsic
alteration of the cell membrane can account for this abnormality.
Arginine vasopressin (AVP) modulates the activity of Na +,K+
cotransport system. D1'EZ J, AREA ZOLA A, VIRT0 R, YAP L,
DIAz—TUEIR0 R, ERJessrl P, PURROY A. Division of Nephrology,
University Clinic, Pamplona, Spain. AVP is able to modify Na
transport across the medullary thick ascending limb of Henle's loop.
Human erythrocytes (E) are an easily accessible tissue whose mem-
brane contains ion transport systems which may serve as models for
epithelial ion pathways. We studied the effect of AVP 10'°M on the
kinetic properties of the interaction of internal Na with different Na
transport pathways in E from normotensive subjects. The main result of
this study was that AVP inhibited by a 40% (P C 0.05) the maximal rate
of outward Na,K cotransport. In addition, the apparent affinity of
the Na,Kt cotransport system for internal Na decreased by a 50%
(P C 0.05) in presence AVP. A similar effect was observed with
bumetaoide 10 - 6M. Forskolin does not modify the kinetic properties of
the interaction of Nat Kt cotransport with internal Nat. Lysine
vasopressin and the AVP analogue (Asu"6,Arg5)-Vasopressin did not
modify Na transport in E. Our findings suggest that AVP may
modulate the activity of Na,K cotransport in E. This effect does not
seem to be mediated by cyclic AMP.
In vitro effects of a diuretic drug, xipamid (X), on the Na and K
transport systems in human erythrocytes (E). DIEz L YAP L, VIRT0 R,
DIAz—TUEIR0 R, ERP..ssTI P, PURROY A, Division of Neplirology,
University Clinic, Pamplona, Spain. X is a diuretic drug whose mech-
anism of action remains unknown. In order to gain insight into the
mechanism of action of X, we explored whether this drug exhibits some
action on Na4 and K transport systems of E. At 10- 3M concentration,
X was able to inhibit by a 50% (P C 0.005) the Na,Kt cotransport
system. In addition, X lO3vi increased the apparent affinity of the
Na4,K cotransport system for internal Na4. A similar effect was
observed with bumetanide I06M. The inhibitory effect of X on
Na,K cotransport decreased in presence of increasing concentra-
tions of bumetanide or chloride in the media. These results let us to
postulate that X may decrease renal Na reabsorption by direct
inhibition of the Na,K,CU cotransport carrier which is located in
the luminal side of Henle's loop cells.
Renal hlood flow and inhibition of free oxigen radicals formation.
MAClAS iF, REVERT ML, MARTIN J, GRANDE J, GOMEZ JR, Hospital
Universitario, Salamanca, and Universidad Aatonoma, Barcelona,
Spain. Renal damage, including diminution of G.F.R., which follows
revascularization after releasing a clamp from the renal artery, can be
prevented in animals previously treated with inhibitors of free-oxygen
radical formation. Xanthync Oxydase (X-O) is an important source of
superoxide in tissues. The aim of the present study is to analyze the
action of the X-O inhibitor, Allopourinol (Al.), on R.B.F. under normal
hemodynamic conditions. Six mongrel dogs were anesthetized with 30
mg/kg of body wt of pcnthobarbital and mechanically ventilated.
Femoral vessels were cannulated, artery fur continous BP recording
and vein for anesthetic and Al injection. The left kidney was exposed
through a subeostal incision and the probe of a electromagnetic flow-
meter placed around the renal artery. Al was given through the femoral
vein in a dose of 10 mg/kg (N = 2), 50 mg/kg (N = 2) and 100 mg/kg
body wt (N 2). Results are shown as Mean I SE of the whole
experimental procedure. R.B.F. was 125,5 10 mI/mm, basal condi-
tions reaching to 170 25 mI/mm (Pc 0.05) after 1 hr of the end of the
injection of Al. R.B.F. was maintained in this range for four hr slowly
returning to basal levels in the next two hours. We conclude that Al, as
it inhibits X-O, consequently reduces the free—oxygen radical formation
rate, which in turn is responsible for an acute elevation of R.B.F.
Secondary hyperparathyroidism and metastasic calcification in uremia.
DE FP.ANctsco ALM, CASSIDY JMD, OWEN JP, ELLtS HA, FARNDON
JM, WARD MK, KERR DNS, University of Newcastle Upon Tyne
(inglaterra), Hospital Nacional Valdecilla, Santander, Spain. In pa-
tients with end stage renal failure, there is an increased incidence of
arterial and soft tissue calcification. It is commonly accepted that the
most important predisposiog factors are the increase in the calcium x
phosphate product and parathyroid hormone. We have studied the
changes in the ectopic calcification after successful parathyroidectomy
(PTX) in 42 uremic patients. Radiological skeletal survey, biochemistry
and bone histology were compared before and at six to 12 months (42
patients), 12 to 14 months (26 patients), or 24 to 48 months (12 patients)
after PTX. The presence of small vessel (SVC) or non-visceral soft
tissue calcification (STC) was not related to the age, sex, duration of
end—stage renal fadure treatment, total serum calcium, magnesium,
phosphate, Ca x P product, alkaline phosphatase, ionized calcium,
serum aluminium, iPTH, severity of radiological and histological
osteitis fibrosa, or parathyroid gland wt. Twenty patients (48%) had
STC and 23 (55%) SVC before parathyroideetomy. Seven patients
developed new and six increased SVC, despite a marked improvement
in subperiosteal erosions and healing of osteitis fibrosa histologically. In
10 patients STC disappeared and in two decreased. In conclusion,
despite reduction in calcium x phosphate product and iPTH, successful
PTX improves non-visceral but not arterial calcification.
Blastic transformation of the uremic lymphocytes. The effect of pros-
taglandins inhihition. GONZALEZ M, DE FRANCISCO ALM, Rutz L,
CANGA E, ZUBIMENDI JA, ARtAS M, Serviclo de Nefrologla, Hospital
Nacional "Marques de Valdecilla", Santander, Spain. In order to
evaluate the effect of the prostaglandins inhibition on the lymphocyte
response in uremia, we have studied the blastic transformation with
phytohemagglutinin (PHA) in presence and absence of uremie serum.
Twenty—eight patients under hemodialysis treatment for more than one
year were compared with 24 healthy age and sex matched donors, used
as controls. Cultures of lymphocytes (X 3) from donors and uremies
were incubated in normal and uremic serum, with and without prosta-
glandins inhibition (indomethacin 1.73 ng/ml). After three days at 37°C
in an atmosphere with 5% C02, tritiated thymidine was added for
measuring the radioactivity 18 hours later. Results are: I) The uremie
lymphocytes showed less PHA blastie transformation than the healthy
controls (P C 0.01) when both were cultured without uremie serum. II)
The uremie serum inhibited the blastic transformation of the normal
lymphocytes. Ill) The uremic lymphocytes exhibited a worse response
when they were cultured with their own serum. IV) The inhibition of the
prostaglandins increased the blastic response in 100% over the non-
inhibited cultures of all the replies, the same from the uremics than from
the donors. In conclusion, the lymphocyte response to PHA was
decreased in uremia because of serum and cellular factors. When the
prostaglandins were suppressed with indomethaein, the blastie trans-
formation with PHA increased in uremies and in healthy control
donors.
Renal graft lost: HLA Sensitization and second transplant. PASTOR JM,
ARIAS M, Lahoratorio de Histocompatibilidad, Servicio de Nefrologlo,
Hospital Nacional "M. de Valdecilla", Santander, Spain. Fifty pa-
tients (31 males and 19 females) between 12 and 55 years of age had
received and rejected a cadaver kidney graft. Twenty—two of them
received a second transplant. All were treated with conventional
eortieosteroid and azathioprine therapy. Before the first transplant,
28.57% had HLA antibodies, and of those only three were women
(7.14% of the total) against more than 50% of the panel's cells. After
rejection, 35 patients (70%) were sensitized, and of them almost half
against more than 50% of the panel's cells. Also, in 17 of them (48.57%
of the sensitized and 34% of the total) the antibodies were HLA specific
of mismatched antigens of the graft: they were anti-HLA-Ai(.l), A2(3),
A3+B5(l), A9(2), A10(2), A11(4), A29(2) and B535(2). The 22 second
transplants patients had a survival of 95,23% and a graft survival of
72.72% at six months. Currently, 15 patients (68.18%) have a function-
ing kidney with an average of 28.20 17.59 months after transplanta-
tion. We have not found significant differences in transfusions (26.57
39.92 vs. 24.67 25.71) nor HLA antibodies (85.6% vs. 60%) between
rejected and accepted second transplants. First graft was lost before
three months in 71.4% and 53.3% respectively. In the group of currently
functioning graft matches A B antigens are 2.32 and mismatched 1.06.
Second graft did not have incompatible HLA antigens of the first graft.
Among the patients with specific antibodies, neither the corresponding
antigen nor those with crossed reactions have been transplanted, except
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in a case who showed acute rejection. Only cases with negative
cross—match test (historical and current serums) have been trans-
planted.
End—stage renal disease registry of the Andalusian region, population
on maintenance treatment at Decemher 31, 1984. Gaivrm MA, GARCIA
UASTRO T, OTERO R, TEJUCA F, PEREZ CALDERON R, GARCIA
VALDECA5 J, OSUNA A, Consejeria de Salud y Consumo, Junta de
Andalocla, Spain. From December 1, 1983 onwards, the above men-
tioned program collected information from all the centers in the region,
meeting data requirements by 99.5%. I. Our prevalence (1,803 patients,
277 patients per million) has increased by 18% along 1984. 2. Distribu-
tion by sex, age and chronic renal failure causal diagnosis did not show
remarkable differences in comparison to that attributed to the whole
country. Neady 30% of the patients suffered from chronic conditions
other than chronic renal disease and its sequela. 3. Center hemodialysis
was the prevalent method (74.9%); HD at home was scarce (2.8%) as
well as kidney transplantation, hut continuous ambulatory peritoneal
dialysis was very often used (9.6%). Along 1984, the percentage of
patients at home decreased and the percentage of tnsnsplant increased.
4. We observed marked cross—province differences regarding preval-
ences, patient type and use of different methods, which are understand-
able on the basis of various criteria of admission and/or treatment
resources availability.
Renal metabolic profile during recuperation of acute hypoxic lactic
acidosis in the dog. JOPRE R, PEREZ GARCIA R, JUNCO F, RENGEL M,
AIoNsoS, VALDERRABANO F, VINAYP, Hospital Provincial, Montreal
University, Madrid, Spain. During acute hypuxic lactic aeidosis in the
dog, the kidney increases simultaneously lactate (La) and glutamine
(GN) extraction, stimulating ammoniagenesis in order to correct acido-
sis and hyperlactacidemia. Acidosis was induced in 21 dogs by venti-
lation with a gas mixture of 9% 02 and 91% N2 during 90 mm, followed
by a recuperation period of 75 mm with normal 02 concentration. Renal
tissue levels of UN, La, pyruvate, atanine, alpha KG were measured
before and after hypoxia recuperation. During hypoxia, lactic acidosis
were developed: pH 7.17, HCO3 14 mEq/liter. Anion gap rose 6
mEq/liter that corresponded to a 5 mat increase of lactate. After 02
normalization, hypoxia was corrected but acidosis persisted: pH 7.16
l-1C03 15 mEq/liter. Anion gap returned to basal levels, and La
decreased to 2 mat. These changes were related to an increase in
chtoremia of 6 mFq/liter. The urinary chloride fell, and U La. V was 3.6
mM/mm. Oxygen consumption, although it remained elevated, de-
creased probably in relation to some degree of hyperlactacidemia and
an increase of renal uptake of La. Renal extraction of UN became
normal although renal production of ammonia continued to be in-
creased. The tissue levels of malate, La, pyruvate and alanine were high
during lactic aeidosis, and partially normalized during the recuperation
period. After hypoxia, hyperlaetaeidemia was corrected in some hours,
but acidosis remained longer, with a normal anion gap.
Oxygen and substrate kidney consumption during acute hypoxic lactic
acidosis in the dog. PEREZ GARCIA R, JUNCO F, JonE R, RENGEL M,
ALONSO 5, VALDERRARANO F, VINA a P, Hospital Provincial,
Universidadde Montreal, Madrid, Spain. In acidotie dogs, the majority
of ATP turnover (80 to 90%) in proximal kidney tubules, is supported by
gtutamine (UN) metabolism. During acidosis, when other substrates are
offered to the kidney, a competitive situation is developed, limited by
the local ATP consumption. To study that relationship, UN, lactate
(LA), citrate, and oxygen renal extraction were measured, and ATP
turnover was calculated from 02 consumption and sodium reabsorption
during acute hypoxic lactic acidosis in the dog in vivo (15 dogs).
Following four normoxic control periods, the dogs were ventilated with
9% 02, 91% N2 during 90 mm (equilibration and four experimental
periods). The kidney tissue concentration of these metabolites were
measured before and after hypoxia. A severe hypoxia was induced (p02
29mm Hg). The dogs developed an acute lactic acidosis (pH 7.17, La
5.1 tLmM) and increased renal extraction of: LA from 119
[onote/min/100 mI/mm GFR to 329; UN from 60 to 98 and citrate from
II to 17. The substrates consumption was related with an increase in 02
consumption from 593 to 851/ttmole/min/100 mt/mm. UFR (P < 0.01).
20% of total ATP turnover was generated from UN, and 71% from LA
in this situation. The exceeding pyruvate not oxidated must be metab-
olized towards glucose production, it can be calculated that an amount
of 153 j.smole/min/l00 mI/mm UFR of pyruvate went into gluconeogen-
esis, with less ATP production. The increase in alanine and glucose
kidney production, and 02 consumption permit an increased uptake of
UN and LA in acute hypoxie lactic aeidosis.
Long—term CAPD treatment: Five years' experience. SELGAS R, P-
FONTAN 34, HUARTE F, MUROZ J, SANZ A, MIGUEL JL, TORRE A,
M-ARA J, S-SJCILIA F, Hospital La Paz, Madrid, Spain. Five patients
(pts) in our hospital have been maintained on CAPD treatment for five
years. Program data are: mortality 12% (among 82 pts); technique
survival after five yr 30% (pt losses caused by frequent peritonitis
and/or sclerosing peritonitis). Dialysis dose: initial (i) 50 8 liter/week
(20%: hypertonic) and current (c) 59 6 liter/wk (19%). Surgically
placed catheter with two dacron cuffs showed fragility and frequent
subcutaneous dacron extrusion after the period of study. Creatinine
clearance was i, 1.5 2; c, 0.2 0.2. Peritoneal functional parameters
were: UF i, 1.1 0.2 ; c, 1.3 0.2 (NS) (in four cases increased).
UREA-MTC was i, 19.4 4.5; c, 14.9 2.8 (in three cases decreased).
Creatinine-MTC were: i, 9.7 2.8; c, 7.8 1.8 (in two decreased).
Current sera data were: BUN 78 ii 9; ereatinine 15.9 1.7; total CO2
22 l.6;K4.4 0.2;P5.2 1;Ca9.5 0.2;A.phos. 102 53;PTH
25 9; Hb 9.5 2; albumin 4.1 t 0.2; cholesterol 211 47;
tryglicerides 203 73; none showed significant differences with respect
to i values. (OH)3 Al intake i and c 2.8 g/day (calcium and/or vit.D
derivatives supplement since 2d year). No changes in radiological bone
parameters were found. No pericarditis incidence (controlled through
eehoeardiographie methods). Nervous conduction velocity showed
slight decrement in three pts. Blood pressure was always in normal
range with minimal or no hypotensive requirements. Metabolic compli-
cations included obesity, hypothyroidism (two old pts) and de nova
diabetes (one pt). Hospitalization rate: 6.3 days/pt/year. Peritonitis
incidence decreased from 1.9 to 0.5 episodes/pt/year since third year.
We conclude that our experience is positive; a better future use of this
technique will show its real possibilities.
Value of thromboxane B2 (TxB2) urinary excretion in the diagnosis of
acute rejection (AR). ORTUIc'a J, REVALDERIA JG, TERUEL JL, VIL-
LAFRUELA JJ, SABATER J, MATESANZ R, QUEREDA C, Servicio de
Nefrologla, Hospital RamOn y Cajal, Madrid, Spain. We prospectively
studied daily urinary excretion of TxB2 in 45 renal transplants in order
to evaluate its value in the diagnosis of acute rejection. These patients
were classified in four groups according to their clinical evolution:
Group A—Composed of 10 cases with good evolution (no rejection or
tubular necrosis). TxB2 was high initially, becoming normal after the
third day post-transplantation. Group B—Twenty—five AR episodes on
grafts with previous good function. Nineteen of them showed elevation
of TxB2 prior to ereatinine increment within an average period of 48 hr.
Group C.—ATN without rejection (five episodes). They showed a
pattern similar to group A. Group D.—AR superimposed on ATN (nine
episodes). Urinary excretion of TxB2 was increased from the beginning
and it persisted until rejection was treated. The values of TxB2 were
highest in this group. Conclusions: Urinary excretion of TxB2 is a useful
parameter in the diagnosis of AR, with high sensitivity (82%) and
specificity (87%) indexes. Its main value consisted in its precocity and
its utility in diagnosing AR on ATN, as the persistence of high urinary
value of TxB2 beyond the third post-transplant day strongly suggests
superimposed AR.
Interstitial pressure dynamics and vascular permeability in rats with
experimental cirrhosis. SANZ F, CARAMEL 0 C, VILLAMEDIANA LM,
SANTOS JC, BLANCt-tART A, HERNANDO L, LOPEz JM, Novoa,
FundociOn Jiménez DIaz, Madrid, Spain. Interstitial pressure (IP)
(Uuyton's capsule) arterial pressure (AP), packed cell volume (PCV),
blood volume (BV), interstitial compliance (IC) and vasapermeability
(VP) were studied in nnn-ascitic, cirrhotic rats (Cl4 C/feuobarbital, N =
10) and in controls drinking fenabarbital (N = 10) by a three step
experiment. In basal conditions, cirrhotic rats showed a positive IP
(0.07 0.07 mm Hg) being negative (—2.6 0.43) in controls (P <
0.01). With extracetlular volume expansion (Ringer, 3% body wt) IP
remained constant in eirrhotics, with elevation in controls (—0.07
0.43) (P < 0.05). With an albumin infusion, Pt increased in cirrhotics
(1.09 0.38 mm Hg), whereas in controls the negativity was enhanced
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(—3.25 1.03) (P <0,001). IC was significantly increased in cirrhotics,
during all the experiments. Vasopermeability, measured by 251-alb-
umin was enhanced in cirrhotics (P < 0.01). In conclusion, cirrhotic rats
have interstitial dynamics and capillary permeability alterations, favor-
ing fluid extravasalion, in a stage before the formation of ascites and/or
edema.
Phosphatidylcholine (PC) metabolism in canine renal cortical tubules
during compensatory renal hypertrophy. MANZANO F, ESBRIT P,
CASTILLA C, RAPADO A, Laboratorio de Ia Unidad Metahólica y
Cirugla Experimental, FundaciOn Jiménez DIaz, Madrid, Spain. Renal
mass loss leads to several mechanisms of compensatory adaptation,
among them an almost immediate enhanced PC synthesis. PC can be
synthesized by two different pathways; The CDP-choline pathway (TC)
involves the transfer of phosphocholine from CDP-choline to
diacylglycerol. The transmethylation pathway (TM) consists of the
addition of three methyl groups to the amino moiety of
phosphatidylethanolamine, catalyzed by the enzyme phospholipid N-
methyltransferase. In these studies, PC synthesis in cortical tubules
taken from a remnant kidney at different times after unilateral nephrec-
tomy (UNX) was compared to that of the control kidney. Homogenized
tubules were incubated with 100 M S-adenosyl-L-(3H-methyl)-
methionine or CDP-('4C-methyl)choline, and then the incorporated
radioactivity in the organic phase was measured. The following results
were obtained:
Enzymatic activity (%)
C 2 hr 24 h 1 week 2 weeks
TM 100 109 12 95 14 96 20 116 4
TC 100 158 26 392 60 206 20 226 15
100% enzymatic activity corresponds to: II 3 (TM) or 334 119
(TC) pmole incorporated xmg protein-'xmin (TM) or x30s '('[C);
SD. An increased PC synthesis by TC pathway was observed 2 hr
after UNX and was maximal at 24 hr. No significant change of TM
pathway was detected within two weeks after UNX compared to
control. The data suggest that the increased PC synthesis during
compensatory renal hypertrophy is not mediated by changes in the TM
pathway.
Hemodynamic effect of atrial natriuretic factor (ANF). CARAMLI.O C,
HERNANDO N, VILLAMEDIANA LM, SANZ E, RODRIGUEZ PUYOL D,
FERNANDEZCRuz A, LOPEZ NovoA JM, FunduciOn Jiménez DIaz, and
the Hospital Cilnico, Madrid, Spain. Protocol A. Urinary electrolyte
excretion, mean arterial pressure (MAP) cardiac output (CU) total
peripheral resistances (TPR) and blood flow were studied in ten Wistar
rats. The hemodynamic measurements were performed by radioactive
microspheres (l5, 57Co, "3Sn) in basal conditions and with synthetic
ANF (2 p.g/kg). The ANF induces a decrease of TPR (—39.25
5.33%), and MAP (P < 0.05) without changes in CO. Splanchnic blood
flow was significantly enhanced (P 0.05), hut the main effect was
detected on renal blood flow, which increased 67.81 9.32% (P <
0.001), with no modifications in blood supply to the other organs.
Urinary Na,K and C1 was raised 6.3 and six times respectively (P
<0.OOl).Protocol B. A possible role of changes in Na' ,K -ATPase by
ANF was studied by the 5Rb transport technique. No differences were
found either in total transport or in Na pump (ouabain—inhibible) or
cotransport (furosemide—sensitive). In conclusion, ANF produces a
selective vasodilation in renal and splanchnic territories which is not
mediated by changes in Nat, K transport.
Enriched suspensions in rat and dog proximal and distal tubules.
LOPEz A&c.4BE C, TEJEDOR A, CONESA D, HERNANDO N, LOPEZ
NovoA JM, FundaciOn Jiménez Diaz, Madrid, Spain. Enriched sus-
pensions of proximal (PT) and distal (DT) tubules of rat and dog kidneys
have been obtained by collagenase (1.5 mg/mI) digestion in
Krebs—Henseleit medium and with consecutive centrifugations in den-
sity gradients of isoosmnotic Percoll (P). The integrity and characteriza-
tion of the tubules were assessed by light and electron microscopy, and
Alkaline phosphatase, glucose-6-phosphatase, hexoquinase and Na-K-
ATPase activity measurements. A homogeneous fraction of PT (30 to
35% in wt of the tubules of digestion) was obtained from a first gradient
generated by in situ isopienic centrifugation of the tubules (35,000 g, 30
mm) in P 50%. Distal tubules (13 to 17%) was obtained by a second
centrifugation of the tipper two layers of the first gradient in the same
conditions, in P 45% for dog tubules and P 42.5% for rat ones. The
viability determined by trypan blue exclusion was about 90% for both
types of tubules. The method described allowed us to obtain, in a single
analytic procedure, a fraction of proximal tubules and another of distal
tubules from rat and dog kidneys.
Studies on arterial hypertension in primary hyperparathyroidism
(PHP). RAPtDO A, GRANT C, Department of Internal Medicine,
FundaciOn Jiménez DIaz, Madrid, Spain. A higher incidence of arterial
hypertension in PHP than in general population has been described.
Several pathogenetic factors have been ascribed in age, renal function
or changes in calcium, phosphorus or magnesium serum levels. We
have revisited ISO cases of PUP pathologically classified as 117
adenomas, 27 hyperplasias and six carcinomas. We define arterial
hypertension as systolic BP  160 and diastolic BP  95 mm Hg.
Forty—five PHP with normal BP has been compared with 45 hyperten-
sive patients. We found 45 PHP patients with arterial hypertension
(30%), an incidence statistically significantly higher than in Spanish
general population (15.5%). Arterial hypertension increased with age
and appeared in younger male patients, leveling after 60 years old.
There were no differences between normal and hypertensive PHP in
renal function, serum calcium, serum phosphorus, serum magnesium,
TmP/GFR or urinary calcium and magnesium indexes, except in
TmP/GFR in normotensive female PUP (P < 0.05). Conclusions:
Arterial hypertension was more frequent in PHP than in the general
population. The youthful presentation in men is worthwhile. There
were no differences between normal and hypertensive patients in
several mineral metabolism parameters analyzed. The multifactorial
pathogenesis of arterial hypertension in general, and in PHP in partic-
ular, demands the study of other parameters (the renin/aldosterone
system, the skeletal sodium, parathormone levels) to define its patho-
genetic role, because the present ones do not demonstrate a unique
etiological factor.
Magnesium deficiency and synthesis of 1,25(OH)2D. in rats. TRARA
ML, DL L.A PIEDRA C, CLIMENT P. RAPADO A, Lahoraiorio Unidad
MetabOlica Fundación Jiménez DIaz, Madrid, Spain. In
hypomagnesemic states, a decrease in the synthesis of I ,25(OH)2D
could exist, because an inhibition of secretion and/or action of parathy-
roid hormone and the I hydroxilase is a Mg-dependent enzyme. We
have studied the transformation of 5H-25(OH)D by injecting 2 j.Ci of
this metabolite to normal (N), hypomagnesemic (—Mg), hypocalcemic
(— Ca), and hypocalcemic—hypomagnescmmc (— Ca-Mg) rats. Forty hr
later, rats were killed, and blood, small intestine, kidney, tibia and
femur were collected. Vitamin D metabolites were extracted with
acetonitrile (serum) and cloroform/methanol,50:50, vol/vol(tissues).
They were purified through Sep—Pak C-IS cartridges and separated by
high performance liquid chromatography (hexane/ethanol 95:5, silica
column). The percentages of radioactivity corresponding to
I ,25(OH)2D1 were calculated with respect to the total radioactivity
contained in each chromatogram.
3H-1 ,25(OH)2D5
Group Serum Bone Kidney Intestine
1(N) 1.9 1.4 5.2 0.8 6.9 2.4 23.0 7.3
ii (-Mg) 1.5 1.0 0.4 0.9 1.5 1.5 11.4 4.3
1-lI NS P < 0.001 P < 0.0025 P < 0.025
III (-Ca) 22,3 6.8 26.3 6.1 40.3 0.8 62.6 4.2
IV (-Ca-Mg) 5.4 3.7 13.4 8.8 8.3 3.3 36.1 2.2
IV-III P <0.0025 P < 0.05 P <0.001 P < 0.001
We observe a decrease in the percentage corresponding to I ,25(OH)2D3
in bone, kidney and intestine in —Mg rats compared to N rats, in
—Ca-Mg rats we find a decrease in 'H-l,25(OH),D3 in serum, bone,
kidney and intestine compared to Ca rats, in spite of hypocalcemia, a
stimulatory factor of the 1 hydroxilase. On the other hand, the levels of
I ,25(OH)2D in serum in — Mg rats are significantly decreased compared
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to N rats (38.9 + 10—68.7 + 25.1, pg/mI, P <0.005). Pram these results
we can suspect that the lack of Mg could inhihit the synthesis of
I ,25(OH)2D3.
Verapamil blunted hemodialysis—induced leukopenia. BONNET F,
(JARAMELO C, Bosct-i R, SANCHEZ CRESPO M, ASADO 5, Fuodacion
Jiménez DIaz, Servicio NefrologIa, Madrid, Spain. We studied ten
hemodialysis (I-ID) hypertensive patients, six males, four females. They
were treated with 240 mg of Verapamil per day, divided into two doses.
Prior to Verapamil they were without any antihypertensive therapy for
seven days. The Verapamil study period was done for seven days. For
HD we utilized hollow fiber cuprohan hemodialyzer of I . I m2 surface
area. Blood samples were taken prior HD and at 15 and 30 mm
thereafter. Blood pressure at the end of the period prior to Verapamil
was 180 8.22/9 6 mm Hg, and was reduced to 152 13/86 8 (P
0.05) at the end of Verapamd treatment. lID-induced leokopenia was
significantly reduced (P 0.026) during the period of Verapamil
treatment as compared to the values netos (Table) or values reduced,
percent, (%) prior to starting of this drug.
Prior Verapamil
Verapamil
Leukopenia (values netos)
30 mm
4.568
5.140
Initial 15 mm
7240 1692.6
7400 4286
Prior Verapamil
Verapamil
Leukopenia (percent reduction)
30 mm
59 15
45 16
Initial 15 mm
100 73 18
100 55 16
In short, Verapamil could be a useful antihypertensive drug in
hemodialysis patients that, in addition, has the intereeting property of
blunting the activity of the neutrofils, and marks a new indication of the
reduced effect of HD-induced leukopenia. This suggests the involve-
ment of extra—cellular calcium entry as a mechanism in
polymorphonueleus leukoeite activation.
Tonsillectomy: A possible therapeutic approach in patients with IgA
nephropathy and episodes of macroscopic hematuria. LOZANO L,
GARCIA—HOYO R, BLASCO R, PraDo J, HERNANDO L, Fundacioo
Jiménez DIrts, Madrid, Spain, We have recently demonstrated that
tonsil lymphocytes from patients with IgA nephropathy produced more
polymeric IgA than those of healthy control subjects. In this work, we
have studied the effect of tonsillectomy on the clinical activity and on
the immunological alterations of eight patients with IgA nephropathy
with boots of macroscopic hematuria. Two years after tonsillectomy the
percentage of polymeric IgA-produeing lymphocytes decreased signif-
icantly in relation to pre-surgical values (42.3 5 vs. 67.4 7).
Coincidentally, there was a disappearance of hematuria episodes and a
significant diminution of microhematuria and proteinuria interhouts.
Furthermore, a significant decrease in the percentage of Ta cells was
noted (10.8 2 vs. 14.7 2) after tonsillectomy. No changes in levels
of serum IgA were observed in vitro synthesis of lgA, in eon-A
generation of T suppressor cells or in OKT4 '-/OKT8 cells ratio. In
summary, these results suggest that tonsillectomy could be a therapeu-
tic approach in patients with IgA nephropathy having boots of macro-
scopic hematuria, and indicate strongly that polymeric IgA may play a
role in the pathogenesis of this disease.
Presence of high levels in the serum of shared idiotypes in patients with
IgA nephropathy. GONZALEZ—CARRERO .L SANCISO J, MOLDENHAUER
F, EoIDo f, Fundación Jiménes Diaz, Madrid, Spain. We have
demonstrated that most of the patients with IgA nephrology have high
levels of antibodies against diet antigens in the serum. We isolated
idiotypic antibodies (Id) anti-bovine serum albumin (BSA) and an
aotologous anti-idiotype from a patient with IgA nephropathy, and also
a heterologous anti-Id from rabbits previously immunized with the Id
(IgO anti-BSA). In this work we have used the heterologous anti-Id to
detect shared idiotypes in sera and immune complexes (IC) from
patients with IgA nephropathy by enzyme—linked immunosorbent assay
(ELISA). We found high serum levels of idiotypic determinants in 50%
of the sera and in 32% of the IC in these patients, and these idiotypie
determinants were shared with IgU antibodies to BSA. These common
or public idiotypes were also significantly increased in serum from
patients with IgA-IC (72%) detected by Raji assay. Concordance was
found between idiotype levels and the presence of hematoria. These
results suggest that in patients with IgA nephropathy, there is a
restriction in the immunological response repertoire; in addition,
idiotypes might be involved in the IC formation and therefore are
implicated in the pathogenesis of this disease.
T and B cells alterations in IgA nephropathy. GARCIA—1-IOYO R,
L0ZAN0 L, BLASCO R, SANCIIE A, Porno J, HERNANDO L, Fundacion
Jiménes DIaz, Madrid, Spain. Previous data have shown that patients
with IgA nephropathy present some specific abnormalities in the
immune regulation of IgA. In order to study if these abnormalities
reside in B or T lymphocytes, or both, we have studied the function of
both cells in 42 patients. In favor of abnormalities in B cells, there was
an increase in the polymeric IgA synthesis in the percentage of B
lymphocytes with IgA Fe receptors (Ba cells) and in the percentage of
IgA bearing cells. In favor of abnormalities of T lymphocytes, we
observed an increase in the percentage of T cells with IgA Fe receptors
(Ta cells) and the activity of T helper function for the IgA synthesis. An
abnormality in the generation of specific IgA suppressor T cells
generated by eon A was also observed. There was a significant
correlation between the polymeric IgA synthesis and the percentage of
To cells. Since it is known that polymeric IgA is able of inducing the
appearance of Ta cells, and the fact that these cells can act as a helper
or suppressor cells, our data suggest that patients with IgA nephropathy
present a primary abnormality of B lymphocytes, probably with an
increased production of polymeric IgA, being a secondary phenomenon
of the abnormality of T cells.
Study of serum acetate (Ac) as a factor in hemodialysis hypotension
(H.H). TORRENTE J, CRUCEYRA A, OLIVAN P. GALLEaO F, Ruiz
GONZALEZ MC, CORONEL F, NARANJO P, BARRIENTOS A, Hospital
ClInico San Carlos. Sm. Nefrologla, Madrid, Spain. The role of Ac in
H.H. is controversial. We measured serum Ac by gas chromatography
in 42 patients submitted to chronic H.D. outside of digitalicous treat-
ment. Ac level into dialysate was 35 mmole/liter. Frequency of H.H.
was retrospectively evaluated in each patient for a period of 6 months.
H.H. was defined as a drop of sistolie pressure below 100 mm Hg.
Serum Ac levels during lID. were measured at 0,1,2,3,4,5 hours in
standard ED. with ultrafiltration (UF), and also in H.D. without UP.
during four hours, followed by one additional hour of pure CF.
According with the levels of serum Ac, patients were divided in group
I (Ac > 5 mmole/liter) 59.5% of patients, and group II (Ac < 5
mmole/liter) 40.5%. Results were: mean serum Ac at 4th hour were 7.0
2.1 and 3.1 0.6 mmole/liter in group I and II respectively (P C
0.005. Frequency of H.H. 26.9% vs. 12.0% P < 0.005. Nonetheless,
there was not any statistical relationship between Ac levels and
frequency of H.H. ED. with and without UP. increased serum Ac in
a similar pattern. One hour at'ter stopping diffusion, serum Ac showed
an equal negative decrease (81.4% vs. 8 1.2%). Conclusions: 1. Patients
who accumulated more Ac had a past history of more HE. 2. U.F. does
not change the pattern of accumulation. 3. A metabolization defect does
not appear to be the cause of more accumulation.
Effect of protein intake on renal function in patients with a solitary
kidney, proteinuria and focal glomerulosclerosis. GUTIERREZ MILLET V.
RUILOPE PM, MORALES JM, PRAGA M, Hospital 1° de Oetobre,
Madrid, Spain. Five patients with a solitary kidney, proteinoria, mild
chronic renal failure and focal glomeruloselerosis on biopsy were
studied. They received a 30 g protein diet for 7 days and thereafter 90
g protein diet for an additional week. Glomerular filtration rate
(GFR;CINU), renal plasma flow (RPF; CPAH), filtration fraction (FF),
urinary excretion of Na (mEq), K (mEq) and proteins (g) in 24 hr.
fractional excretion of Na (FENa) and plasma renin activity (PRA) were
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Diet
GFR
(mi/mm)
RPF
(mi/mm)
FEN
(%)
a Proteinuria
(g/day)
30 g protein 41 13 180 49 0.79 .8 3.5 1.8
90g protein 60 12* 314 133* 1.07 .6 4.9 2.4*
evaluated at the end of every week period. The results show: (*p <0.05
by X2 test). The increase in protein intake resulted in a parallel elevation
of GFR (46%), RPF (74%) and proteinuria (40%). There were not
significant changes in UNa, FENa, UK or PRA. The results suggest
that a protein load in these patients produces an increase in GFR, RPF
and proteinuria, and thereby causes an increase of the previously
established hyperfiltration.
Renal pathology findings in patients with a solitary kidney and protein-
uria. MILLET VG, PRAGA M, NIETO J, Rooeiio FG, MORALES JM,
ALCAZAR JM, BELLO I, Hospital 10 do Octubre, Madrid, Spain. Ten
patients (M/F:8/2) aged between 28 and SI, with a solitary kidney and
proteinuria, and without evidence of hypertension, systemic disease,
urinary tract infection or chronic drug ingestion were studied .,Six had
a previous nephrectomy: atrophic tuberculous pyelonephritis (3), renal
hypoplasia (I), stagorn lithiasis (1), and hypernephroma (I) without
involvement of the contralateral kidney. The remaining four had
unilateral renal agenesis. Proteinuria ranged between 1 . I and 4. I g/day
(X:2.7 g/day), being in the nephrotic range in 4. Four patients had mild
to moderate chronic renal failure and two microhematuria. The IVP
showed different degrees of compensatory hypertrophy and the
cystography ruled out vesicoureteral refiux on the solitary kidney. All
patients had a surgical kidney biopsy. By light microscopy, nine had
focal glomerulosclerosis (FG) and I, minimal changes (MC). Six to 25%
of glomeruli had segmental sclerosis and 4 to 50% global sclerosis
(obsolescent glomeruli). By IF, 8 showed granular deposits of C3 and 4
of 1gM over the sclerotic areas. The case with MC did not have deposits
by IF. however, EM studies revealed mesangial dense deposits. We
concluded that patients with a solitary kidney and proteinuria may have
a high incidence of FG.
Diffuse pulmonary hemorrhage (DPH) associated with glomerulone-
phritis (GN). PRAGA M, ANDRES A, GUTIERREZ-RODERO F,
LUMBRERAS C, GUTIERREZ MILLET V, MORLAES JM, NIETO J,
RoDiclo JL, Hospital 1° do Octubre, Madrid, Spain. Of 760 primary
and secondary ON studied in a ii year period, nine (1.1%) presented
with DPH. The diagnosis was Goodpasture's syndrome (G5) in two
patients (lineal IgG IF, anti-GBM antibodies), idiopathic extracapillary
ON with negative IF in four HBsAg-associated vasculitis in one,
Schonlein—Henoch purpura in one and focal and segmental glomerular
sclerosis (FSG) in one. Only patients with OS showed positive anti-
GBM antibodies. Every bout of DPH was accompanied by severe
hypoxemia and anemia, without differences between US and non-anti-
GBM mediated GN. At the onset of DPH, only two patients had normal
renal function; serum creatinine oscillated between 2,2 to 13 mg/dl in
the remainder. Renal biopsy, performed in every case showed crescents
(30 to 90% of glomeruli) in seven patients; only Schonlein.-Henoch and
HBsAg positive patients exhibited signs of vasculitis in renal vessels.
Lung biopsy, obtained in six cases, showed iotra-alveolar bleeding and
hemosiderosis, without vasculitis. One patient (FSG) did not receive
any treatment; his renal function remained normal, hut he died because
of a DPH two years later. Eight patients were treated with prednisolone
pulses and cyclophosphamide. plus piasmapheresis in five of them.
Predisolone pulses had a clearly beneficial effect on DPH. Of the eight
treated patients, only three had new episodes of DPH after treatment.
Their renal function improved in four, worsened in three, and remained
stable in one. In conclusion, most (77%) of the UN associated with DPH
were non-mediated by anti-GBM antibodies. No clinical differences
were observed between these patients and those with SG.
Computer handling of clinical data for dialysis. ALCAZAR J, Roi'cio
JL, ALVAREZ—UDE F, PEREZ DIAz V, MOREU E, MOLINERO L,
CARRASCO Li, S. IvefrologIa, 1 do Octubre, Hospital Gral. do Segovia,
Hospital Clinico do Valladolid, Harris—Soft, and University Auldnon2a,
Madrid, Spain. The clinical management of patients on dialysis relies
on an ever increasing accumulation of exact data. We designed a
software package which facilitates the process by showing all the details
of each patient plus the relationships between the other patients.. This
amplifies the raw data for a larger picture of the dialysis trends in our
center. The program was designed by three dialysis centers in collab-
oration with equipment engineers. It requires a personal computer
(IBM XT) with 6 bits and a central memory of 256 kilobytes, and which
uses disketts or hard discs of 10 Mbyte. The program is user friendly for
every member of the staff to operate. Information such as personal
dates, blood type, HLA, date of each dialysis, date of complications,
biochemical dates, pathology, vascular access, rehabilitation and treat-
ment, is consolidated on a monographic screen which produces three
types of monitoring. These are: daily during a weekly period, monthly,
and quarterly. In every monitoring cycle, the program provides space
for comments. The program includes processing that disseminates all
types of information and is updated automatically. For instance, a user
can access records of each patient or group of patients and run a
bio-statistic program (INVEST) which analyzes individual or collective
dates. This utilizes qualitatives or quantitatives that are changeable
parametric and non-parametric tests of analyses and graphic represen-
tations. One application is the selection of transplant recipients.
